Detailed price information for Immunoprecise Antibodies Ltd (IPA-Q) from The Globe and Mail including charting and trades.

ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA),an AI-driven biotherapeutic research and technology company, announces the details of its upcoming TECHDAY event on ...

ImmunoPrecise Antibodies (IPA) has released an update. ImmunoPrecise Antibodies is set to host TECHDAY, showcasing its cutting-edge ...

VICTORIA, British Columbia, September 16, 2024--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology ...

VICTORIA, British Columbia, November 04, 2024--ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, announces the details ...

VICTORIA, British Columbia — ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, announces the details of its upcoming ...

Detailed price information for Immunoprecise Antibodies Ltd (IPA-Q) from The Globe and Mail including charting and trades.

Presentation by Dr. Shuji Sato: Dr. Sato will present IPA’s B Cell Discovery Platform and discuss its integration with the company’s advanced AI and NGS workflows for highly efficient hit ...

VICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. ("IPA" or the "Company") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology ...

ImmunoPrecise Antibodies Ltd. ("IPA" or the "Company") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, announces its significant contribution to a groundbreaking study.

Highlights,ImmunoPrecise Antibodies,(NASDAQ:IPA),contributes to a significant study on mitochondrial dysfunction.,The ...